Next Weeks Broker Price Targets For CytRx Corporation (CYTR)

Hedge funds and other institutional investors have recently bought and sold shares of the company. The market capitalization of the company is at $107.82 Million. Relative Strength Index (RSI) was 72.07. RSI oscillates between zero and 100.

CytRx Corporation (CYTR) is an interesting player in the Healthcare space, with a focus on Biotechnology.

To stay one step ahead we extended our research by comparing different price targets. It represents a security’s price that, if achieved, results in a trader recognizing the best possible outcome for his investment. Its book value per share for the most recent quarter is $0.13 while its price to book ratio for the same period is 6.54, as for as the company’s cash per share for the most recent quarter is $0, however its price to cash per share ratio for the same period is 0.

Weighted Alpha is used to calculate how much a share has gone up or down over a certain period, normally a year.

All things being equal, stocks with higher earnings-per-share growth rates are generally more desirable than those with slower earnings-per-share growth rates.

Earnings per share (EPS) is the portion of a company’s profit allocated to each outstanding share of common stock. EPS breaks down the profitability of the company on a single share basis. It’s the most up-to-date valuation until trading begins again on the next day.

Since the beginning of the calendar year, the stock is 128.37%. The mean revenue estimate is $-0.5M.

Microsoft Corporation (NASDAQ:MSFT) traded at a yearly high level of $70.74 during the last trading session.

Revenue is the amount of money that a company actually receives during a specific period, including discounts and deductions for returned merchandise. On average, equities research analysts predict that CytRx will post ($0.50) EPS for the current year.

P/E of the company is not reported.

A moving average (MA) is a trend-following or lagging indicator because it is based on past prices. Regardless, closing prices are a useful tool that investors use to quantify changes in stock prices over time. There are advantages to using a moving average in your trading, as well options on what type of moving average to use. Look at the direction of the moving average to get a basic idea of which way the price is moving. At recent session, the prices were hovering between $0.61 and $0.73.

Stock market analysts and brokers have recently amended their target prices on shares of CytRx Corporation (CYTR). Beta can be useful to gauge stock price volatility in relation to the broader market. The SEC filing shows that Patterson Scott Bradford performed a purchase of 50,000 shares.

A number of research firms have issued reports on CYTR. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock.

CytRx Corporation had its ” rating reiterated by analysts at H.C. Wainwright. It seems that American Tower Corporation (NYSE:AMT) might see weakness given an ABR of 3.2 or Sell rating.

By historical standards, CytRx Corporation remains a cheap stock.

CytRx Corporation shares increased 68.68 percent over the past week and rose 67.81 percent over the previous month.

Leave a Reply

Your email address will not be published. Required fields are marked *